Advisors Management Group Inc Novavax Inc Transaction History

Advisors Management Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 20, 2022	SELL	$69.73 - $142.9 $697,300 - $1.43 Million	-10,000 Closed	0 $0
Q4 2021 Jan 31, 2022	SELL	$134.56 - $217.97 $134,560 - $217,970	-1,000 Reduced 9.09%	10,000 $1.43 Million
Q3 2021 Oct 28, 2021	SELL	$177.8 - $270.58 $181,533 - $276,262	-1,021 Reduced 8.49%	11,000 $2.28 Million
Q2 2021 Jul 21, 2021	SELL	$121.0 - $257.67 $82,159 - $174,957	-679 Reduced 5.35%	12,021 $2.55 Million
Q1 2021 Apr 14, 2021	SELL	$112.98 - $319.93 $372,834 - $1.06 Million	-3,300 Reduced 20.63%	12,700 $2.3 Million
Q3 2020 Nov 10, 2020	BUY	$79.44 - $178.51 $1.27 Million - $2.86 Million	16,000 New	16,000 $1.73 Million

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $629M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Advisors Management Group Inc , based on Form 13F filings with the SEC.

Stay updated on Advisors Management Group Inc with notifications on news.